Evidence for an instructive mechanism of de novo methylation in cancer cells (original) (raw)

• Monk, M., Boubelik, M. & Lehnert, S. Temporal and regional changes in DNA methylation in the embryonic, extraembryonic and germ cell lineages during mouse embryo development. Development 99, 371–382 (1987).
  CAS PubMed Google Scholar
• Kafri, T. et al. Developmental pattern of gene-specific DNA methylation in the mouse embryo and germline. Genes Dev. 6, 705–714 (1992).
  Article CAS Google Scholar
• Brandeis, M. et al. Sp1 elements protect a CpG island from de novo methylation. Nature 371, 435–438 (1994).
  Article CAS Google Scholar
• Macleod, D., Charlton, J., Mullins, J. & Bird, A.P. Sp1 sites in the mouse Aprt gene promoter are required to prevent methylation of the CpG island. Genes Dev. 8, 2282–2292 (1994).
  Article CAS Google Scholar
• Lock, L.F., Takagi, N. & Martin, G.R. Methylation of the HPRT gene on the inactive X occurs after chromosome inactivation. Cell 48, 39–46 (1987).
  Article CAS Google Scholar
• Gidekel, S. & Bergman, Y. A unique developmental pattern of Oct-3/4 DNA methylation is controlled by a cis-demodification element. J. Biol. Chem. 277, 34521–34530 (2002).
  Article CAS Google Scholar
• Robertson, K.D. & Wolffe, A.P. DNA methylation in health and disease. Nat. Rev. Genet. 1, 11–19 (2000).
  Article CAS Google Scholar
• Baylin, S.B. & Herman, J.G. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 16, 168–174 (2000).
  Article CAS Google Scholar
• Jones, P.A. & Laird, P.W. Cancer epigenetics comes of age. Nat. Genet. 21, 163–167 (1999).
  Article CAS Google Scholar
• Jones, P.A. & Baylin, S.B. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3, 415–428 (2002).
  Article CAS Google Scholar
• Costello, J.F. et al. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat. Genet. 24, 132–138 (2000).
  Article CAS Google Scholar
• Zardo, G. et al. Integrated genomic and epigenomic analyses pinpoint biallelic gene inactivation in tumors. Nat. Genet. 32, 453–458 (2002).
  Article CAS Google Scholar
• Yu, L. et al. Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia. Nat. Genet. 37, 265–274 (2005).
  Article CAS Google Scholar
• Issa, J.P. CpG island methylator phenotype in cancer. Nat. Rev. Cancer 4, 988–993 (2004).
  Article CAS Google Scholar
• Chan, A.O. et al. CpG island methylation in aberrant crypt foci of the colorectum. Am. J. Pathol. 160, 1823–1830 (2002).
  Article CAS Google Scholar
• Toyota, M. et al. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res. 59, 5438–5442 (1999).
  CAS PubMed Google Scholar
• Ahuja, N. & Issa, J.P. Aging, methylation and cancer. Histol. Histopathol. 15, 835–842 (2000).
  CAS PubMed Google Scholar
• Baylin, S. & Bestor, T.H. Altered methylation patterns in cancer cell genomes: cause or consequence? Cancer Cell 1, 299–305 (2002).
  Article CAS Google Scholar
• Rush, L.J. & Plass, C. Restriction landmark genomic scanning for DNA methylation in cancer: past, present, and future applications. Anal. Biochem. 307, 191–201 (2002).
  Article CAS Google Scholar
• Smiraglia, D.J. & Plass, C. The study of aberrant methylation in cancer via restriction landmark genomic scanning. Oncogene 21, 5414–5426 (2002).
  Article CAS Google Scholar
• Weber, M. et al. Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat. Genet. 37, 853–862 (2005).
  Article CAS Google Scholar
• Mukhopadhyay, R. et al. The binding sites for the chromatin insulator protein CTCF map to DNA methylation-free domains genome-wide. Genome Res. 14, 1594–1602 (2004).
  Article CAS Google Scholar
• Toyota, M. et al. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res. 59, 2307–2312 (1999).
  CAS PubMed Google Scholar
• Stirzaker, C., Song, J.Z., Davidson, B. & Clark, S.J. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells. Cancer Res. 64, 3871–3877 (2004).
  Article CAS Google Scholar
• Maruyama, R. et al. Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features. Clin. Cancer Res. 8, 514–519 (2002).
  CAS PubMed Google Scholar
• Odom, D.T. et al. Control of pancreas and liver gene expression by HNF transcription factors. Science 303, 1378–1381 (2004).
  Article CAS Google Scholar
• Suzuki, H. et al. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat. Genet. 31, 141–149 (2002).
  Article CAS Google Scholar
• Segal, E., Yelensky, R. & Koller, D. Genome-wide discovery of transcriptional modules from DNA sequence and gene expression. Bioinformatics 19 (Suppl.), i273–i282 (2003).
  Article Google Scholar
• Su, A.I. et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc. Natl. Acad. Sci. USA 101, 6062–6067 (2004).
  Article CAS Google Scholar
• Notterman, D.A., Alon, U., Sierk, A.J. & Levine, A.J. Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res. 61, 3124–3130 (2001).
  CAS PubMed Google Scholar
• Esteller, M. et al. DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. Hum. Mol. Genet. 10, 3001–3007 (2001).
  Article CAS Google Scholar
• Di Croce, L. et al. Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science 295, 1079–1082 (2002).
  Article CAS Google Scholar
• Feltus, F.A., Lee, E.K., Costello, J.F., Plass, C. & Vertino, P.M. Predicting aberrant CpG island methylation. Proc. Natl. Acad. Sci. USA 100, 12253–12258 (2003).
  Article CAS Google Scholar
• Varambally, S. et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419, 624–629 (2002).
  Article CAS Google Scholar
• Cao, R. & Zhang, Y. The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3. Curr. Opin. Genet. Dev. 14, 155–164 (2004).
  Article CAS Google Scholar
• Plath, K. et al. Role of histone H3 lysine 27 methylation in X inactivation. Science 300, 131–135 (2003).
  Article CAS Google Scholar
• Silva, J. et al. Establishment of histone H3 methylation on the inactive X chromosome requires transient recruitment of Eed-Enx1 polycomb group complexes. Dev. Cell 4, 481–495 (2003).
  Article CAS Google Scholar
• Vire, E. et al. The Polycomb group protein EZH2 directly controls DNA methylation. Nature advance online publication 14 December 2005 (10.1038/nature04431).
  Google Scholar
• Eden, S., Hashimshony, T., Keshet, I., Thorne, A.W. & Cedar, H. DNA methylation models histone acetylation. Nature 394, 842–843 (1998).
  Article CAS Google Scholar